Cremophor ELHans Gelderblom, Alex Sparreboom, Jaap Verweij et al.|European Journal of Cancer|2001Cited by 1.6k
Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).Ron H.J. Mathijssen, Alex Sparreboom|PubMed|2001Cited by 752
Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumorsWilliam L. Dahut, William D. Figg, James L. Gulley et al.|Cancer Biology & Therapy|2006Cited by 155
Characterization of in vitro and in vivo metabolic pathways of the investigational anticancer agent, 2‐methoxyestradiolNehal J. Lakhani, William D. Figg, Alex Sparreboom et al.|Journal of Pharmaceutical Sciences|2007Cited by 38
MATE1 Deficiency Exacerbates Dofetilide-Induced ProarrhythmiaMuhammad Erfan Uddin, Alex Sparreboom|International Journal of Molecular Sciences|2022Cited by 10